title: Norway backs downs over plan to exclude anticancer drugs from coverage.
authors.forename: Anders
authors.initials: A
authors.lastname: Hansen
mesh_terms: D000736:Androstenes; D000737:Androstenols / Q000191:economics* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D019458:Insurance Coverage; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D000074324:Ipilimumab; D009313:National Health Programs / Q000458:organization & administration*; D009664:Norway
chemical_list: D000736:Androstenes; D000737:Androstenols; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab; C089740:abiraterone